These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27089599)

  • 1. [New guidelines for screening and management of familial dyslipidemia].
    Brun N; Aubert CE; Nanchen D; Rodondi N
    Rev Med Suisse; 2016 Mar; 12(508):435-9. PubMed ID: 27089599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First insights from the EAS familial hypercholesterolaemia collaboration registry: FH is still underdiagnosed and undertreated.
    Stock J
    Atherosclerosis; 2019 Nov; 290():138-139. PubMed ID: 31610884
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dyslipidemia - when are lipid lowering medications useful in clinical practice?].
    Blum MR; Stanga Z; Rodondi N
    Praxis (Bern 1994); 2013 May; 102(10):585-9. PubMed ID: 23644243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of European and US guidelines for familial hypercholesterolaemia.
    Reiner Ž
    Curr Opin Lipidol; 2015 Jun; 26(3):215-20. PubMed ID: 25943839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.
    Civeira F;
    Atherosclerosis; 2004 Mar; 173(1):55-68. PubMed ID: 15177124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology.
    De Backer G; Besseling J; Chapman J; Hovingh GK; Kastelein JJ; Kotseva K; Ray K; Reiner Ž; Wood D; De Bacquer D;
    Atherosclerosis; 2015 Jul; 241(1):169-75. PubMed ID: 25997074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of familial hypercholesterolemia in children and adolescents].
    Ose L; Tonstad S; Vesterhus P; Wefring KW
    Tidsskr Nor Laegeforen; 1995 Nov; 115(28):3499-503. PubMed ID: 7491603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.
    Mundal L; Sarancic M; Ose L; Iversen PO; Borgan JK; Veierød MB; Leren TP; Retterstøl K
    J Am Heart Assoc; 2014 Dec; 3(6):e001236. PubMed ID: 25468658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous familial hypercholesterolemia case study.
    Friedrich DA
    J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypercholesterolemia in children and adolescents.
    McCrindle BW
    Curr Opin Lipidol; 2012 Dec; 23(6):525-31. PubMed ID: 22914663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pharmacologic treatments for familial hypercholesterolemia.
    McDonough A; Matura LA; Carroll D
    Nurs Womens Health; 2013 Oct; 17(5):443-7. PubMed ID: 24138664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing early cardiovascular death in patients with familial hypercholesterolemia.
    Repas TB; Tanner JR
    J Am Osteopath Assoc; 2014 Feb; 114(2):99-108. PubMed ID: 24481802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification, and Misinterpretation Versus Facts.
    Knowles JW; Stone NJ; Ballantyne CM
    Am J Cardiol; 2015 Aug; 116(3):481-4. PubMed ID: 26043952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How to deal with familial dyslipidemia in clinical practice?].
    Brun N; Rodondi N
    Rev Med Suisse; 2012 Mar; 8(331):494-6, 498-500. PubMed ID: 22471110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of familial hypercholesterolemia and of the dyslipidemias responsible for cardiovascular disease].
    Sampietro T; Licitra R
    G Ital Cardiol; 1999 Feb; 29(2):171-3. PubMed ID: 10088075
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk assessment and strategies to achieve lipid goals: lessons from real-world clinical practice.
    Schuster H
    Am J Med; 2004 Mar; 116 Suppl 6A():26S-30S. PubMed ID: 15050189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
    Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
    Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypercholesterolemia: a missed opportunity in preventive medicine.
    Watts GF; Lewis B; Sullivan DR
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):404-5. PubMed ID: 17593912
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.